The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children

This publication has 14 references indexed in Scilit:

• Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care
  Respiratory Medicine, 1998
• Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less
  Respiratory Medicine, 1998
• Cost effectiveness of fluticasone and budesonide in patients with moderate asthma.
  Clinical Drug Investigation, 1998
• Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety
  Respiratory Medicine, 1997
• Efficacy and Cost Benefit of Inhaled Corticosteroids in Patients Considered to Have Mild Asthma in Primary Care Practice
  Canadian Respiratory Journal, 1996
• A blinded comparison of fluticasone propionate with budesonide via powder devices in adult patients with moderate‐to‐severe asthma: a clinical evaluation
  Mediators of Inflammation, 1996
• The Episode-Free Day as a Composite Measure of Effectiveness
  PharmacoEconomics, 1993
• Cost Effectiveness of Inhaled Corticosteroid plus Bronchodilator Therapy versus Bronchodilator Monotherapy in Children with Asthma
  PharmacoEconomics, 1993
• Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
  Archives of Disease in Childhood, 1993
• The Cost of Asthma
  PharmacoEconomics, 1993